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Objectives: Long term survival after lung transplantation has signiﬁcantly improved
during the last 10 years. On the other hand, complications have increased. Renal
diseases, most probably related to the immunosuppression therapy and cystic ﬁbrosis
therapy such as antibiotic threrapy, are important complications during the follow-
up.
Methods: During the period November 1996 up to now 84 lung transplantation
recipients with with cystic ﬁbrosis (40 males) followed in our center according to a
pre-established follow-up protocol for Tx patients: During the follow-up period
all patients developed renal complications. The mean time of occurrence after
lung transplantation was 12 months. All patients have reduced immunosuppression
therapy during the follow-up period (in 10 patient Tacrolimus was changed to
Rapamycin) Three patients (2 females) developed severe renal complications after
8, 10, 13 years after lung transplantation, and underwent kidney transplantation.
Two pts are alive after 4 and 1 year after renal transplantation with good pulmonary
function (FEV1 65% and 85% predicted) normal creatinine serum level and good
creatinine clereance. One pt (female) died after 1 year after renal transplantation
due to bronchiolitis obliterans syndrome.
Conclusion: Renal diseases after lung transplantation are an important complica-
tion; A multidisciplinary approach is needed since the beginning of the follow-
up, in order to obtain precocious diagnosis and establish an adequate therapy.
Kidney transplantation for our opinion is a good opportunity in pts with severe
renal complication.
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In Cystic Fibrosis the paranasal sinuses are often smaller than in the healthy
population. It is assumed that paranasal sinus disease during development inhibits
pneumatization of the sinuses, but also the temporal bone. Interestingly, a few
studies described an increased pneumatization of the temporal bone in CF patients
compared to healthy controls. This seems contradictory and underlying mechanisms
remain unclear. Moreover, differences in pneumatization between patients with
different CF genotypes have been described. A direct inﬂuence of the CFTR
mutation on the temporal bone pneumatization (TBP) has been suggested.
Objectives: With a prospective study in 104 adult patients with CF we investigated
temporal bone pneumatization and a possible correlation with CF genotype.
Methods: In 104 adult patients a CT scan of the temporal bone was performed.
Patients were divided into 2 groups according to their genotype with mutation class
I-III as severe CF and mutation class IV-V as mild CF. TBP was estimated by two
assessors using a validated scale. To assess the interobserver agreement a Cohen’s
kappa was calculated.
Results: In total 208 temporal bones from 104 patients were assessed; 31 patients
with mild CF and 73 with severe CF. The Cohen’s kappa was 0.85, which indicates a
substantial agreement between the two assessors. TBP differed signiﬁcantly between
the mild CF and severe CF group (x2 = 0.002), with a greater TBP in the severe
CF group.
Conclusion: Severe CF seems associated with greater TBP. Strikingly, patients with
severe CF did not display less pneumatized temporal bones, where they often have
less pneumatized paranasal sinuses.
